EFFICACY OF DESMOPRESSINA IN PATIENT WITH ACTIVE BLEEDING AFTER HEART SURGERY. - ND

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-005199-33-IT

Enrollment

108

Registered

2006-01-31

Start date

2006-03-13

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIGH BLEEDING AFTER HEART SURGERY MedDRA version: 6.1 Level: HLGT Classification code 10007593

Interventions

Trade Name: EMOSINT INIETT.10F 20 MCG/ML Pharmaceutical Form: Solution for infusion INN or Proposed INN: Desmopressin CAS Number: 62357-86-2 Concentration unit: µg microgram(s) Concentration type: equ

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -HEART SURGERY; -HOSPEDALIZATION IN INTENSIVE CARE UNIT WITH HIGH BLEEDING FOR ABOUT 1 HOUR BLEEDING 100 ML IN THE LAST 30 MINUTES OR PATINTS WITH HIGH BLEEDING 2ML/kG/MIN FOR AT LEAST 2 HOURS Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: -PATIENTS WITH AGE LOWER THAN 18; -LACK OF INFORMED CONSENT

Design outcomes

Primary

Measure	Time frame
Main Objective: EVALUATION OF DESMOPRESSINA USE VS PLACEBO IN BLOOD TRANSFUSIONS REDUCTION IN PATIENTS WITH HIGH POSTOPERATIVE BLEEDING.;Secondary Objective: PLEASE SEE PRIMARY OBJECTIVE;Primary end point(s): share of patients that have bloodtransfusion during hospitalization in heartsurgery intensive care after desmopressina vs placebo administration.	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026